Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma

CompletedOBSERVATIONAL
Enrollment

183

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

February 24, 2021

Study Completion Date

June 10, 2022

Conditions
SilicosisPneumoconiosis; Silica
Interventions
DIAGNOSTIC_TEST

Tuberculosis test

Tuberculosis (TB) test: A blood sample is collected for lab testing to determine if you have tuberculosis (QuantiFeron test). Alternatively, the test is done by injecting a small amount of fluid (called tuberculin) into the skin on the lower part of the arm. A person given the tuberculin skin test must return within 48 to 72 hours to have a trained health care worker look for a reaction on the arm.

DIAGNOSTIC_TEST

Chest X-ray

Chest X ray: non-invasive medical test that helps physicians diagnose and treat medical conditions of the lungs and chest. The Chest X-ray will be done to check for abnormalities on the lungs. The test is non-invasive.

DIAGNOSTIC_TEST

Pulmonary Function Test

A pulmonary function test (PFT, spirometry) is a breathing test that measures how much air your lungs can hold as well as how hard and fast you can blow air out of your lungs. The test is not invasive and involves blowing into a machine.

Trial Locations (1)

73104

University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT04205708 - Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma | Biotech Hunter | Biotech Hunter